Industry Research Reports

Home > Reports > Pharma & Healthcare > Aprepitant Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Aprepitant Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-10

Pages: 105 Pages

Report ld: 3015021

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.

The global market for Aprepitant Capsules was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Aprepitant capsules are widely used for the prevention of nausea and vomiting during both the induction and subsequent phases of chemotherapy. With the continuous evolution of the oncology field, Aprepitant capsules have solidified their position in the market, leading to a gradual expansion of its market size. Its outstanding clinical performance has resulted in sustained sales growth, establishing it as a key player in the management of nausea and vomiting. Furthermore, as research into supportive therapies for cancer treatment advances, Aprepitant capsules hold the potential for further application and development in a broader spectrum of nausea and vomiting prevention, ultimately offering enhanced quality of life for patients.

MARKET SEGMENTATION

By Company

Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

80mg
125mg
Other

Segment by Application

Hospital
Pharmacy
Other

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Aprepitant Capsules, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aprepitant Capsules by region & country, by Type, and by Application.

The Aprepitant Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant Capsules.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Aprepitant Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Aprepitant Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Aprepitant Capsules in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Aprepitant Capsules Product Introduction

1.2 Global Aprepitant Capsules Market Size Forecast

1.2.1 Global Aprepitant Capsules Sales Value (2019-2030)

1.2.2 Global Aprepitant Capsules Sales Volume (2019-2030)

1.2.3 Global Aprepitant Capsules Sales Price (2019-2030)

1.3 Aprepitant Capsules Market Trends & Drivers

1.3.1 Aprepitant Capsules Industry Trends

1.3.2 Aprepitant Capsules Market Drivers & Opportunity

1.3.3 Aprepitant Capsules Market Challenges

1.3.4 Aprepitant Capsules Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Aprepitant Capsules Players Revenue Ranking (2023)

2.2 Global Aprepitant Capsules Revenue by Company (2019-2024)

2.3 Global Aprepitant Capsules Players Sales Volume Ranking (2023)

2.4 Global Aprepitant Capsules Sales Volume by Company Players (2019-2024)

2.5 Global Aprepitant Capsules Average Price by Company (2019-2024)

2.6 Key Manufacturers Aprepitant Capsules Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Aprepitant Capsules Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Aprepitant Capsules

2.9 Aprepitant Capsules Market Competitive Analysis

2.9.1 Aprepitant Capsules Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Aprepitant Capsules Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant Capsules as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 80mg

3.1.2 125mg

3.1.3 Other

3.2 Global Aprepitant Capsules Sales Value by Type

3.2.1 Global Aprepitant Capsules Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Aprepitant Capsules Sales Value, by Type (2019-2030)

3.2.3 Global Aprepitant Capsules Sales Value, by Type (%) (2019-2030)

3.3 Global Aprepitant Capsules Sales Volume by Type

3.3.1 Global Aprepitant Capsules Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Aprepitant Capsules Sales Volume, by Type (2019-2030)

3.3.3 Global Aprepitant Capsules Sales Volume, by Type (%) (2019-2030)

3.4 Global Aprepitant Capsules Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.1.3 Other

4.2 Global Aprepitant Capsules Sales Value by Application

4.2.1 Global Aprepitant Capsules Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Aprepitant Capsules Sales Value, by Application (2019-2030)

4.2.3 Global Aprepitant Capsules Sales Value, by Application (%) (2019-2030)

4.3 Global Aprepitant Capsules Sales Volume by Application

4.3.1 Global Aprepitant Capsules Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Aprepitant Capsules Sales Volume, by Application (2019-2030)

4.3.3 Global Aprepitant Capsules Sales Volume, by Application (%) (2019-2030)

4.4 Global Aprepitant Capsules Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Aprepitant Capsules Sales Value by Region

5.1.1 Global Aprepitant Capsules Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Aprepitant Capsules Sales Value by Region (2019-2024)

5.1.3 Global Aprepitant Capsules Sales Value by Region (2025-2030)

5.1.4 Global Aprepitant Capsules Sales Value by Region (%), (2019-2030)

5.2 Global Aprepitant Capsules Sales Volume by Region

5.2.1 Global Aprepitant Capsules Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Aprepitant Capsules Sales Volume by Region (2019-2024)

5.2.3 Global Aprepitant Capsules Sales Volume by Region (2025-2030)

5.2.4 Global Aprepitant Capsules Sales Volume by Region (%), (2019-2030)

5.3 Global Aprepitant Capsules Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Aprepitant Capsules Sales Value, 2019-2030

5.4.2 North America Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Aprepitant Capsules Sales Value, 2019-2030

5.5.2 Europe Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Aprepitant Capsules Sales Value, 2019-2030

5.6.2 Asia Pacific Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Aprepitant Capsules Sales Value, 2019-2030

5.7.2 South America Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Aprepitant Capsules Sales Value, 2019-2030

5.8.2 Middle East & Africa Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Aprepitant Capsules Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Aprepitant Capsules Sales Value

6.2.1 Key Countries/Regions Aprepitant Capsules Sales Value, 2019-2030

6.2.2 Key Countries/Regions Aprepitant Capsules Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Aprepitant Capsules Sales Value, 2019-2030

6.3.2 United States Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Aprepitant Capsules Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Aprepitant Capsules Sales Value, 2019-2030

6.4.2 Europe Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Aprepitant Capsules Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Aprepitant Capsules Sales Value, 2019-2030

6.5.2 China Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

6.5.3 China Aprepitant Capsules Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Aprepitant Capsules Sales Value, 2019-2030

6.6.2 Japan Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Aprepitant Capsules Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Aprepitant Capsules Sales Value, 2019-2030

6.7.2 South Korea Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Aprepitant Capsules Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Aprepitant Capsules Sales Value, 2019-2030

6.8.2 Southeast Asia Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Aprepitant Capsules Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Aprepitant Capsules Sales Value, 2019-2030

6.9.2 India Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

6.9.3 India Aprepitant Capsules Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Aprepitant Capsules Product Offerings

7.1.5 Merck Recent Development

7.2 Sandoz

7.2.1 Sandoz Company Information

7.2.2 Sandoz Introduction and Business Overview

7.2.3 Sandoz Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sandoz Aprepitant Capsules Product Offerings

7.2.5 Sandoz Recent Development

7.3 Glenmark Pharmaceuticals

7.3.1 Glenmark Pharmaceuticals Company Information

7.3.2 Glenmark Pharmaceuticals Introduction and Business Overview

7.3.3 Glenmark Pharmaceuticals Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Glenmark Pharmaceuticals Aprepitant Capsules Product Offerings

7.3.5 Glenmark Pharmaceuticals Recent Development

7.4 Chia Tai Tianqing Pharmaceutical Group

7.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information

7.4.2 Chia Tai Tianqing Pharmaceutical Group Introduction and Business Overview

7.4.3 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Offerings

7.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Development

7.5 Qilu Pharmaceutical

7.5.1 Qilu Pharmaceutical Company Information

7.5.2 Qilu Pharmaceutical Introduction and Business Overview

7.5.3 Qilu Pharmaceutical Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Qilu Pharmaceutical Aprepitant Capsules Product Offerings

7.5.5 Qilu Pharmaceutical Recent Development

7.6 Camber Pharma

7.6.1 Camber Pharma Company Information

7.6.2 Camber Pharma Introduction and Business Overview

7.6.3 Camber Pharma Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Camber Pharma Aprepitant Capsules Product Offerings

7.6.5 Camber Pharma Recent Development

8 Industry Chain Analysis

8.1 Aprepitant Capsules Industrial Chain

8.2 Aprepitant Capsules Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Aprepitant Capsules Sales Model

8.5.2 Sales Channel

8.5.3 Aprepitant Capsules Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Aprepitant Capsules Market Trends

Table 2. Aprepitant Capsules Market Drivers & Opportunity

Table 3. Aprepitant Capsules Market Challenges

Table 4. Aprepitant Capsules Market Restraints

Table 5. Global Aprepitant Capsules Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Aprepitant Capsules Revenue Market Share by Company (2019-2024)

Table 7. Global Aprepitant Capsules Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Aprepitant Capsules Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Aprepitant Capsules Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Aprepitant Capsules Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Aprepitant Capsules Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Aprepitant Capsules

Table 13. Global Aprepitant Capsules Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant Capsules as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Aprepitant Capsules Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Aprepitant Capsules Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Aprepitant Capsules Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Aprepitant Capsules Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Aprepitant Capsules Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Aprepitant Capsules Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Aprepitant Capsules Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Aprepitant Capsules Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Aprepitant Capsules Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Aprepitant Capsules Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Aprepitant Capsules Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Aprepitant Capsules Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Aprepitant Capsules Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Aprepitant Capsules Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Aprepitant Capsules Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Aprepitant Capsules Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Aprepitant Capsules Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Aprepitant Capsules Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Aprepitant Capsules Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Aprepitant Capsules Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Aprepitant Capsules Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Aprepitant Capsules Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Aprepitant Capsules Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Aprepitant Capsules Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Aprepitant Capsules Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Aprepitant Capsules Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Aprepitant Capsules Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Aprepitant Capsules Sales Value by Region (2019-2024) & (%)

Table 44. Global Aprepitant Capsules Sales Value by Region (2025-2030) & (%)

Table 45. Global Aprepitant Capsules Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Aprepitant Capsules Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Aprepitant Capsules Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Aprepitant Capsules Sales Volume by Region (2019-2024) & (%)

Table 49. Global Aprepitant Capsules Sales Volume by Region (2025-2030) & (%)

Table 50. Global Aprepitant Capsules Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Aprepitant Capsules Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Aprepitant Capsules Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Aprepitant Capsules Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Aprepitant Capsules Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Aprepitant Capsules Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Aprepitant Capsules Sales Volume, (2025-2030) & (K Units)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Merck Aprepitant Capsules Product Offerings

Table 61. Merck Recent Development

Table 62. Sandoz Company Information

Table 63. Sandoz Introduction and Business Overview

Table 64. Sandoz Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Sandoz Aprepitant Capsules Product Offerings

Table 66. Sandoz Recent Development

Table 67. Glenmark Pharmaceuticals Company Information

Table 68. Glenmark Pharmaceuticals Introduction and Business Overview

Table 69. Glenmark Pharmaceuticals Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Glenmark Pharmaceuticals Aprepitant Capsules Product Offerings

Table 71. Glenmark Pharmaceuticals Recent Development

Table 72. Chia Tai Tianqing Pharmaceutical Group Company Information

Table 73. Chia Tai Tianqing Pharmaceutical Group Introduction and Business Overview

Table 74. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Offerings

Table 76. Chia Tai Tianqing Pharmaceutical Group Recent Development

Table 77. Qilu Pharmaceutical Company Information

Table 78. Qilu Pharmaceutical Introduction and Business Overview

Table 79. Qilu Pharmaceutical Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Qilu Pharmaceutical Aprepitant Capsules Product Offerings

Table 81. Qilu Pharmaceutical Recent Development

Table 82. Camber Pharma Company Information

Table 83. Camber Pharma Introduction and Business Overview

Table 84. Camber Pharma Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Camber Pharma Aprepitant Capsules Product Offerings

Table 86. Camber Pharma Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Aprepitant Capsules Downstream Customers

Table 90. Aprepitant Capsules Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Aprepitant Capsules Product Picture

Figure 2. Global Aprepitant Capsules Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Aprepitant Capsules Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Aprepitant Capsules Sales Volume (2019-2030) & (K Units)

Figure 5. Global Aprepitant Capsules Sales Price (2019-2030) & (US$/Unit)

Figure 6. Aprepitant Capsules Report Years Considered

Figure 7. Global Aprepitant Capsules Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Aprepitant Capsules Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Aprepitant Capsules Revenue in 2023

Figure 10. Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 80mg Picture

Figure 12. 125mg Picture

Figure 13. Other Picture

Figure 14. Global Aprepitant Capsules Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Aprepitant Capsules Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Aprepitant Capsules Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Aprepitant Capsules Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Aprepitant Capsules Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Pharmacy

Figure 21. Product Picture of Other

Figure 22. Global Aprepitant Capsules Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Aprepitant Capsules Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Aprepitant Capsules Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Aprepitant Capsules Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Aprepitant Capsules Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Aprepitant Capsules Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Aprepitant Capsules Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Aprepitant Capsules Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Aprepitant Capsules Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Aprepitant Capsules Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Aprepitant Capsules Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Aprepitant Capsules Sales Volume (%), (2019-2030)

Figure 39. United States Aprepitant Capsules Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Aprepitant Capsules Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Aprepitant Capsules Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Aprepitant Capsules Sales Value by Application (%), 2023 VS 2030

Figure 45. China Aprepitant Capsules Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

Figure 47. China Aprepitant Capsules Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Aprepitant Capsules Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Aprepitant Capsules Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Aprepitant Capsules Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Aprepitant Capsules Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Aprepitant Capsules Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Aprepitant Capsules Sales Value by Application (%), 2023 VS 2030

Figure 57. India Aprepitant Capsules Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030

Figure 59. India Aprepitant Capsules Sales Value by Application (%), 2023 VS 2030

Figure 60. Aprepitant Capsules Industrial Chain

Figure 61. Aprepitant Capsules Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Aprepitant Capsules market? zhanKai

The top companies in the global Aprepitant Capsules market are Merck、Sandoz、Glenmark Pharmaceuticals.

Related Reports

Global Aprepitant Capsules Market Research Report 2025
The global market for Aprepitant Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 87
USD 2900.00
(Single User License)
Global Aprepitant Capsules Market Insights, Forecast to 2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published Date: 2024-04-12
Pages: 90
USD 4900.00
(Single User License)
Global Aprepitant Capsules Market Research Report 2024
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published Date: 2024-01-17
Pages: 77
USD 2900.00
(Single User License)

Global Aprepitant Capsules Market Research Report 2025
The global market for Aprepitant Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 87
USD 2900.00 (Single User License)
Global Aprepitant Capsules Market Insights, Forecast to 2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published: 2024-04-12
Pages: 90
USD 4900.00 (Single User License)
Global Aprepitant Capsules Market Research Report 2024
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published: 2024-01-17
Pages: 77
USD 2900.00 (Single User License)